synthetase (CarA) from P. carotovorum. CarA catalysed the
conversion of compounds 7, 17a/17b, 10, 15a, and 13 to their
respective bicyclic b-lactam derivatives 18, 19a, 19b, 20, 21,
and 22 as demonstrated by LC-MS analyses (Fig. 3). In case of
10, 15a and 13, the CarA reaction was scaled-up and the
structures of the isolated products were confirmed by NMR
analyses (20: Fig. 2, S19 and S20, 21: Fig. S21 and 22: Fig. S22,
ESIw). In the case of the CarA catalysed reaction of the
mixture of 15a and 15b, we observed selective conversion of
15a to give 21.
In conclusion, we have demonstrated the utility of carboxy-
methylproline synthases as biocatalysts for preparing functionalised
N-heterocycles in a diastereoselective fashion, and that the
products can be converted into the respective bicyclic
b-lactams of potential application in the semisynthesis of
stable b-lactam antibiotics. More generally, the results illustrate
the potential of the crotonase superfamily enzymes for
biocatalysis.
Fig. 3 LC-MS data (negative ion mode) for the bicyclic b-lactams
produced by CarA catalysis.
We thank the BBSRC, the Ministry of Higher Education,
Egypt (R. B. H.), and the Deutsche Akademie der Naturforscher
Leopoldina, Germany (BMBF-LPD 9901/8-137 to C.D.), for
funding, Dr Edward T. Batchelar for helpful discussions, and Dr
Ian Clifton for assistance with Fig. 1.
formation was detected by NMR analyses (pD 7.7). In
contrast, for 4, 9 and 12, which are substrates, the imine form
was detected. The fraction of the imine form (pD 7.7) varied as
follows: 4 (imine to other forms, 49 : 1), 9 (imine to other
forms, B1 : 1) and 12 (imine to other forms, B1 : 9) as
analysed by integrating the imine C–H versus the Ca–H
resonances.
Notes and references
1 R. F. Li, A. Stapon, J. T. Blanchfield and C. A. Townsend, J. Am.
Chem. Soc., 2000, 122, 9296–9297.
2 S. J. McGowan, M. Sebaihia, S. O’Leary, K. R. Hardie, P. Williams,
G. S. A. B. Stewart, B. W. Bycroft and G. P. C. Salmond, Mol.
Microbiol., 1997, 26, 545–556.
3 L. E. Nunez, C. Mendez, A. F. Brana, G. Blanco and J. A. Salas,
Chem. Biol., 2003, 10, 301–311.
4 R. B. Hamed, E. T. Batchelar, I. J. Clifton and C. J. Schofield, Cell.
Mol. Life Sci., 2008, 65, 2507–2527.
5 E. T. Batchelar, R. B. Hamed, C. Ducho, T. D. W. Claridge,
M. J. Edelmann, B. Kessler and C. J. Schofield, Angew. Chem., Int.
Ed., 2008, 47, 9322–9325.
6 B. Gerratana, S. O. Arnett, A. Stapon and C. A. Townsend,
Biochemistry, 2004, 43, 15936–15945.
7 M. C. Sleeman and C. J. Schofield, J. Biol. Chem., 2004, 279,
6730–6736.
8 M. C. Sleeman, J. L. Sorensen, E. T. Batchelar, M. A. McDonough
and C. J. Schofield, J. Biol. Chem., 2005, 280, 34956–34965.
´
9 R. B. Hamed, E. T. Batchelar, J. Mecinovic, T. D. W. Claridge and
C. J. Schofield, ChemBioChem, 2009, 10, 246–250.
10 G. Grogan, G. A. Roberts, D. Bougioukou, N. J. Turner and
S. L. Flitsch, J. Biol. Chem., 2001, 276, 12565–12572.
11 J. L. Sorensen, M. C. Sleeman and C. J. Schofield, Chem.
Commun., 2005, 1155–1157.
12 H. Shin, E. Cama and D. W. Christianson, J. Am. Chem. Soc.,
2004, 126, 10278–10284.
13 J. Hamilton-Miller, J. Antimicrob. Chemother., 1999, 44, 729–734.
14 J. Earl and P. Kirkpatrick, Nat. Rev. Drug Discovery, 2003, 2,
97–98.
15 J. Rothstein, S. Patel, M. Regan, C. Haenggeli, Y. Huang,
D. Bergles, L. Jin, M. Hoberg, S. Vidensky and D. Chung, Nature,
2005, 433, 73–77.
16 L. C. Blaszczak, R. F. Brown, G. K. Cook, W. J. Hornback,
J. M. Indelicato, C. L. Jordan, A. S. Katner, M. D. Kinnick and
J. H. McDonald, J. Med. Chem., 2002, 33, 1656–1662.
We then investigated the ability of the carboxymethyl-
proline synthases to catalyse the formation of C-7/C-8
alkylated 6- and 7-membered N-heterocycles, respectively.
Incubation of 9 with CarB and C-2 epimeric methylmalonyl-
CoA 8 led to the observation of the two C-7 methyl-substituted
epimers (15a and 15b) in a B2 : 1 ratio (entry 4, Table 1).
Assignment of the stereochemistry at C-7 was hindered by
rotation about the C-6–C-7 bond; b-lactam ring formation
enabled assignment of the stereochemistry at C-7 of 15a as R
(Fig. S21, ESIw). Incubation of 9 with ThnE and 8 led to no
detectable observation of a product with the anticipated
m/z 202 [M + H]+ by LC-MS. Incubation of 12 with
CarBH229A and 8 led to the observation of a single chromato-
graphic peak with m/z 216 [M + H]+ corresponding to
8-methyl-CMAC 16 (entry 6, Table 1); no detectable product
was observed with wild-type CarB. The yield of 16 was too low
for stereochemical assignment at C-7/C-8 by NMR.
b-Lactams are used therapeutically not only as antibiotics,
but also as protease inhibitors (e.g. inhibition of HIV protease),13
to reduce cholesterol levels14 and as neuroprotective agents.15
Moreover, although many b-lactams including penicillin and
cephalosporins are produced by semisynthesis, others including
carbacephems (which are known to have higher chemical and
serum stability than cephalosporins16) are produced by
expensive total synthesis. The carboxymethyl-functionalised
N-heterocycles, generated in this study, were therefore tested
as substrates for the b-lactam forming enzyme carbapenam
ꢀc
This journal is The Royal Society of Chemistry 2010
Chem. Commun., 2010, 46, 1413–1415 | 1415